These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2046837)

  • 1. Treatment with deferoxamine: a real risk factor for mucormycosis?
    Vlasveld LT; van Asbeck BS
    Nephron; 1991; 57(4):487-8. PubMed ID: 2046837
    [No Abstract]   [Full Text] [Related]  

  • 2. Fatal Rhizopus infections in hemodialysis patients receiving deferoxamine.
    Windus DW; Stokes TJ; Julian BA; Fenves AZ
    Ann Intern Med; 1987 Nov; 107(5):678-80. PubMed ID: 3662280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucormycosis--a new risk of deferoxamine therapy in dialysis patients with aluminum or iron overload?
    Goodill JJ; Abuelo JG
    N Engl J Med; 1987 Jul; 317(1):54. PubMed ID: 3587314
    [No Abstract]   [Full Text] [Related]  

  • 4. Deferoxamine therapy and mucormycosis in dialysis patients: report of an international registry.
    Boelaert JR; Fenves AZ; Coburn JW
    Am J Kidney Dis; 1991 Dec; 18(6):660-7. PubMed ID: 1962650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies.
    Boelaert JR; de Locht M; Van Cutsem J; Kerrels V; Cantinieaux B; Verdonck A; Van Landuyt HW; Schneider YJ
    J Clin Invest; 1993 May; 91(5):1979-86. PubMed ID: 8486769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of desferrioxamine in dialysis-associated mucormycosis: report of three cases and review of the literature.
    Boelaert JR; van Roost GF; Vergauwe PL; Verbanck JJ; de Vroey C; Segaert MF
    Clin Nephrol; 1988 May; 29(5):261-6. PubMed ID: 3293856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatal fungal peritonitis in an adolescent on continuous ambulatory peritoneal dialysis: association with deferoxamine.
    Nakamura M; Weil WB; Kaufman DB
    Pediatr Nephrol; 1989 Jan; 3(1):80-2. PubMed ID: 2702092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cunninghamella bertholletiae infection associated with deferoxamine therapy.
    Rex JH; Ginsberg AM; Fries LF; Pass HI; Kwon-Chung KJ
    Rev Infect Dis; 1988; 10(6):1187-94. PubMed ID: 3060947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deferoxamine treatment as a risk factor for zygomycete infection.
    Sane A; Manzi S; Perfect J; Herzberg AJ; Moore JO
    J Infect Dis; 1989 Jan; 159(1):151-2. PubMed ID: 2909637
    [No Abstract]   [Full Text] [Related]  

  • 10. [A case report of rhinocerebral mucormycosis in hemodialysis patient receiving deferoxamine].
    Arizono K; Fukui H; Miura H; Hayano K; Otsuka Y; Tajiri M
    Nihon Jinzo Gakkai Shi; 1989 Jan; 31(1):99-103. PubMed ID: 2747004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of arterial thrombus of Mucorales hyphae during deferoxamine therapy in a patient with aplastic anemia in transformation to myelodysplastic syndrome].
    Miyata Y; Kajiguchi T; Saito M; Takeyama H
    Rinsho Ketsueki; 2000 Feb; 41(2):129-34. PubMed ID: 10723242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucormycosis infection in dialysis patients.
    Boelaert JR; Vergauwe PL; Vandepitte JM
    Ann Intern Med; 1987 Nov; 107(5):782-3. PubMed ID: 3662297
    [No Abstract]   [Full Text] [Related]  

  • 13. Mucormycosis: association with deferoxamine therapy.
    Daly AL; Velazquez LA; Bradley SF; Kauffman CA
    Am J Med; 1989 Oct; 87(4):468-71. PubMed ID: 2679077
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of deferoxamine, feroxamine and iron on experimental mucormycosis (zygomycosis).
    Van Cutsem J; Boelaert JR
    Kidney Int; 1989 Dec; 36(6):1061-8. PubMed ID: 2601256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucormycosis in deferoxamine-treated patients on dialysis.
    Veis JH; Contiguglia R; Klein M; Mishell J; Alfrey AC; Shapiro JI
    Ann Intern Med; 1987 Aug; 107(2):258. PubMed ID: 3605912
    [No Abstract]   [Full Text] [Related]  

  • 16. Intestinal mucormycosis in hemodialysis patients following deferoxamine.
    Eiser AR; Slifkin RF; Neff MS
    Am J Kidney Dis; 1987 Jul; 10(1):71-3. PubMed ID: 3605086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal mucormycosis in a hemodialysis patient treated with desferrioxamine.
    Kaneko T; Abe F; Ito M; Hotchi M; Yamada K; Okada Y
    Acta Pathol Jpn; 1991 Jul; 41(7):561-6. PubMed ID: 1755321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhinocerebral mucormycosis in haemodialysis patients treated with desferrioxamine: possible role of recent surgery as an additional risk factor.
    Wens R; Devriendt J; Collart F; Dratwa M; Bisschop P; Telerman-Toppet N; Douat N
    Nephrol Dial Transplant; 1991; 6(9):656-8. PubMed ID: 1745390
    [No Abstract]   [Full Text] [Related]  

  • 19. Indolent zygomycosis associated with deferoxamine chelation therapy.
    Prokopowicz GP; Bradley SF; Kauffman CA
    Mycoses; 1994; 37(11-12):427-31. PubMed ID: 7659131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rhinocerebral mucormycosis during deferoxamine therapy].
    Ammon A; Rumpf KW; Hommerich CP; Behrens-Baumann W; Rüchel R
    Dtsch Med Wochenschr; 1992 Sep; 117(38):1434-8. PubMed ID: 1526205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.